.
Revised April, 2025 – Resource: Turkey Medicals, International Patient Center
.
.
BEST 4 PRICES ▷ BMT IN ISTANBUL AND ANTALYA ▷ TRANSPLANT COST AND REVIEW
| . BONE MARROW TRANSPLANT (BMT) KNOWN AS A HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), IS A MEDICAL PROCEDURE IN WHICH DISEASED OR DAMAGED BONE MARROW IS REPLACED WITH HEALTHY BONE MARROW. BONE MARROW IS THE SOFT TISSUE INSIDE BONES THAT PRODUCES BLOOD CELLS, INCLUDING RED BLOOD CELLS, WHITE BLOOD CELLS, AND PLATELETS. THIS PROCEDURE IS TYPICALLY USED TO TREAT CERTAIN TYPES OF BLOOD CANCERS LIKE LEUKEMIA, LYMPHOMA, AND MULTIPLE MYELOMA, AND AS OTHER CONDITIONS THAT AFFECT THE BONE MARROW, SUCH AS SEVERE ANEMIA OR IMMUNE DISORDERS. . |
.
You may review testimonials on Youtube @medicalparkinternational for before / after patient videos.
.
.
ONE OF THE LARGEST HEALTHCARE VIP HOSPITALS GROUP IN THE REGION
.
WE DO THE LATEST UPDATES, RATINGS AND REVIEWS, SO YOU DON’T HAVE TO
We have a comprehensive range of services, offering the best medical plans at the lowest competitive prices for choice. All health facilities in Turkey own ISO 9001 certificate, JCI Accreditation, for their clinical services and also offer 5-star hotel comforts to International guests.
Our International Patient Center is designed as a “one-stop” service center for healthcare consultation from the day of your request until the time you return to your home country. It is the initial point of contact for acquiring information, orientation and registration.
Turkey Medicals simply helps start your medical travel to Antalya and Istanbul cities to take treatment vacation, fast and easy, and safe. After entered Turkey our professional staff is dedicated 7/24 to all your services, for diagnostic, billing and insurance, travel and lodging, language interpretation.
.
.
VIDEO REVIEW OF BEFORE AND AFTER TREATMENT FOR BEST TURKEY EXPERIENCE
You may subscribe to Youtube @medicalpark with 28.5K subscribers and review 1.1K videos.
.
.
WHY CHOOSE TURKEY FOR BONE MARROW TRANSPLANT SURGERY?
Bone marrow transplants in Turkey (BMT) are complex and life-saving procedures often required for patients with the conditions such as leukemia, lymphoma, aplastic anemia, and other severe blood or immune system disorders. Turkey, particularly Istanbul and Antalya, has gained recognition for its advanced bone marrow transplant centers and high-quality healthcare services. Many international patients travel to these cities for bone marrow transplants due to Turkey’s affordable healthcare, skilled medical professionals, and modern facilities.
-
Istanbul is the leading city in Turkey for bone marrow transplants. The city is home to several world-class hospitals and medical centers that specialize in hematology, oncology, and stem cell therapy. As a major medical tourism hub, Istanbul attracts patients from around the world seeking autologous (self-donated) or allogeneic (donor-based) bone marrow transplants.
. -
Many international patients, especially from Europe, the Middle East, Russia, and North Africa, visit Istanbul for bone marrow transplants due to high success rates and more affordable costs compared to their home countries.
. - Istanbul likely performs 500 to 800 bone marrow transplantations annually, including both local and international patients. A significant portion of these transplants involves international medical tourists due to Istanbul’s reputation for excellence in hematology and oncology.
.
Antalya sees about 50 to 100 bone marrow transplant patients annually. While Antalya’s share of bone marrow transplants is smaller, the number is gradually increasing as the city becomes more established in the medical tourism industry.
-
Antalya, while not as large or as well-known for bone marrow transplants as Istanbul, is increasingly developing as a medical tourism destination. Our hospital in Antalya is offering bone marrow transplant services with highly skilled medical teams, though it is a smaller part of the medical tourism landscape compared to Istanbul.
. -
Many patients who seek bone marrow transplants in Antalya often choose the city for its affordable healthcare and its relaxed environment, combining medical care with recovery in a more scenic, resort-style setting.
. -
Antalya likely performs around 50 to 100 bone marrow transplants annually. This number is growing as the city gains more recognition for its medical tourism offerings, although it still lags behind Istanbul in terms of volume.
.
Turkey’s healthcare system, especially in cities like Istanbul and Antalya, is known for cutting-edge technology, highly skilled specialists, and internationally accredited hospitals. These factors contribute to the city’s appeal for complex procedures like bone marrow transplants. Bone marrow transplantations in Turkey are significantly more affordable compared to countries like the USA, Germany, or the UK. Surgeons, hematologists, and oncologists in Istanbul and Antalya are highly trained, many with experience in top institutions in the U.S., Europe, and other countries. Our top hospitals are specialized in stem cell treatments, bone marrow transplants, and cancer care.
.
Istanbul remains the dominant city for bone marrow transplantations in Turkey, with a significant number of international patients traveling for the procedure each year. Antalya, while still a smaller player in this field, is slowly growing in popularity for medical tourism related to hematology and oncology. Both cities offer affordable and high-quality medical care, making them attractive destinations for patients seeking bone marrow transplants. The combination of skilled medical professionals, cutting-edge technology, affordable treatment costs are key factors that continue to drive the demand for bone marrow transplants in both cities.
.
.
BONE MARROW TRANSPLANT PRICE RANGES IN TURKEY MEDICAL CENTERS
The cost of a bone marrow transplantation (BMT) in Istanbul and Antalya can vary significantly depending on factors such as the type of transplant (autologous vs. allogeneic), the hospital or medical center, the complexity of the case, the patient’s health condition, and the type of care and facilities included.
.
-
Autologous Bone Marrow Transplant (Auto BMT): This type of transplant involves using the patient’s own stem cells or bone marrow to treat the disease. It’s commonly used for patients with conditions such as lymphoma, multiple myeloma, and some forms of leukemia.
.
Istanbul cost ranges between $25,000 to $35,000 USD. Price can vary depending on the hospital, the complexity of case, and patient’s condition. Cost generally includes hospitalization, chemotherapy (if required), stem cell collection, processing, and follow-up care.
.
Antalya cost ranging from $20,000 to $30,000 USD. Prices in Antalya tend to be more affordable due to lower overall medical expenses in the region. Costs typically covers entire process, including pre-transplant evaluations, stem cell collection, transplant, and post-transplant care.
. -
Allogeneic Bone Marrow Transplant (Allo BMT): This type involves using donor bone marrow or stem cells to treat the disease. It’s generally used for patients with certain types of leukemia, aplastic anemia, or bone marrow failure syndromes. For the donor may be related (family member) or unrelated (donor registry).
.
Istanbul cost ranges from $40,000 to $70,000 USD. The cost is higher for allogeneic transplants due to the additional complexity involved, such as finding a suitable donor, and the longer and more intensive hospitalization required. Costs generally includes donor search (if needed), matching, stem cell processing, pre-transplant chemotherapy, transplant procedure itself, and post-transplant recovery and monitoring.
.
Antalya cost ranges from: $35,000 to $60,000 USD, depending on the hospital, the need for a donor match, and the overall complexity of the case. Costs includes all aspects of procedure such as donor matching, chemotherapy, transplant, hospitalization, and follow-up care.
.
.
BONE MARROW TRANSPLANT NEW RESEARCH AND CONFERENCES IN TURKEY
Experts who gave information at the 12. National Congress on Bone Marrow Transplantation and Cellular Treatment in Turkey emphasized that bone marrow transplantation is important in important blood diseases such as leukemia, Mediterranean anemia and bone marrow failure. The importance of being a donor was mentioned at the congress and information was given about the developments in treatment.
In addition to being the largest organization held regularly in Turkey, it also remains one of the few most important meetings among its counterparts abroad, in 12th National Bone Marrow Transplantation and Cellular Treatments Congress, was held in Muğla on March 5-7, 2020.
In addition to the growing number of bone marrow transplants in Turkey and accumulation of knowledge and transplantation research that is multiplying exponentially in this area further increases the importance of the congress. The scientific program of the Congress was extremely rich this year, as expected. For two days, national and international speakers specializing in their fields took part in the congress.
In the scientific program, the issues of stem cell transplantation in adults and children were discussed in all aspects and up-to-date data were presented by very valuable scientists. in the congress, which included 14 scientific sessions, 3 courses, 86 oral presentations and scientific subcommittee meetings were held. 118 session chairs and speakers took part in the congress. About 500 participants came to the congress.
The first day of the congress began with a Course of Controversial Issues and Difficult Facts.
Speakers and session moderators transplantation were examined in detail with valuable and up to date with developments in the scientific program discussed the problems and solutions searched for.
In addition to physicians, the training of nurses and other employees plays an important role in the success of bone marrow transplant units. In this context, this year is the 6th. Transplantation Coordinators Course and 12th a Bone Marrow Transplantation and Apheresis Nursing Training Program was organized.
The Turkish Society of Hematology, which attaches great importance to Coordinator and Nurse training, supported the participation of one trainee from each bone marrow transplant center in the congress in order to achieve the goal of the courses and to ensure nationwide participation.
.
VIDEO REVIEW OF JCI AMERICAN ACCREDITED WORLD AWARDED HOSPITALS IN TURKEY
.
.
BECOMING A STEM CELL DONOR IN ACUTE LEUKEMIA FOR CANCER TREATMENT
Michigan University Faculty of Medicine Internal Medicine Hematology Lecturer Prof. Dr. emphasized that bone marrow transplantation in the world is being applied more and more frequently because it can provide a complete recovery in important blood diseases such as the Leukemia, Mediterranean anemia and a bone marrow failure.
For a successful stem cell transplant, patients must have an appropriate voluntary donor (donor). In Turkey, most of the donors are selected from among brothers and sisters. Because domestic donors are easier to find than in other countries. In the event that a suitable donor is not found, it is investigated that he will choose a non-relative donor. Domestic bank in bone marrow (TURKOK, TRIS, TRAN) voluntary unrelated donor or the donor pool from banks from overseas is trying to find.
Being a donor is based on volunteerism. Volunteer donors donate stem cells not only for related patients, but also for people they don’t know, and don’t expect any benefit from it. Currently, the number of voluntary donors in the world has reached 30 million. Since all of these donors are healthy people, attention is paid to donor safety. Since side effects that can be considered serious to date are rare and the procedure is safe, volunteer people continue to donate stem cells. For donor safety, donors are given a thorough preliminary assessment before transplantation. Stem cells are collected after donors whose health status is eligible for stem cell donation have been granted eligibility for collection.
.
The process of collecting blood stem cells from donors is similar to a normal blood donation process. After collection, donors return to their daily lives. Bone marrow collection from the donor may be required depending on the patient’s condition. Superficial anesthesia can be given so that pain is not felt when collecting bone marrow. Before all these procedures, donors must give their consent after a thorough notification to be made to them.
.
THE DONOR TARGET IN TURKEY IS 800 THOUSAND
Stating that there are currently around 600 thousand donors in Turkey, it is expected that this number will reach around 800 thousand in the coming period, the President of the Turkish Hematological Association Prof. Dr. said, “I would like to point out that it no longer makes much sense to increase the donor a lot after a certain number. Because after that, the probability of finding a gene for tissue groups that are considered very difficult is low. a donor of about 800 thousand is a good figure. Being a real donor, it is important that the rejection rates are low. When we look at the donor pool in Turkey, there is actually a young pool that is desired. It can be preferred. However, there are situations where the family has a say in the abandonment, especially due to our family structure, until the ages of 25-30. Sometimes donors can give up as a result of family and spouse resources,” he said.
.
CAR T CELL THERAPIES ADVANTAGE IN TURKEY MEDICAL CENTERS
General Secretary of the Turkish Society of Hematology Professor Doctor, on the other hand, conveyed the latest developments related to CAR T cell treatments:
The immune system considers substances that enter the body from the outside as foreign and tries to destroy them by attacking.
CAR T cell therapy is based on the principle that white blood cells, which are part of the immune system and are called T lymphocytes, are sensitized to a certain type of cancer in the laboratory and given to the patient.
In order to better understand how CAR T cell therapy works, it may be helpful to know a little more about the relationship between the immune system and cancer. The immune system recognizes and destroys foreign substances in the body through structures called antigens located on their surface. Cancer cells also have some special antigens located on their surface, but immune system cells (especially T lymphocytes) cannot always recognize these antigens, so it is difficult to understand that cancer cells are foreign to the body. This condition facilitates the spread of cancer. T lymphocytes use structures called receptors to recognize the antigen of a cancer cell. With the help of receptors, they attach to the antigen on the cancer cell and eliminate it. But if T cells do not have the appropriate receptor, they cannot bind to the cancer cell and help destroy the cell.
In CAR T cell therapy, first of all, T lymphocytes are collected from the cancer patient’s own blood with the help of a machine. Then, man-made receptors (called chimeric antigen receptor or CAR) are placed on these T-cells in the laboratory that recognize the antigen of the cancer found in the patient. After that, these T cells that will attack the cancer are returned to the patient by a vein, allowing him to fight cancer cells.
This can be summarized as the fact that a person’s own immune system is artificially sensitized to cancer. In order to make the treatment more successful, it is important to reduce the number of cancer cells that the immune system will cope with. For this purpose, chemotherapy may be given to the patient a few days before CAR T cell therapy.
Currently, there are two CAR T cell therapies approved for use in blood and lymph cancers in theUnited States. Although it has not yet been clarified whether these treatments will result in a long-term full recovery, many patients have benefited from the treatment. However, side effects that may be fatal due to CAR T cell therapy have also been observed. Scientists are also investigating the long-term side effects of this treatment choice. Other CAR T cell treatment studies are underway to treat different types of cancer.
.
Turkey's world-renowned organ transplant specialist Demirbaş who has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
.
1. What is a bone marrow transplant?
A bone marrow transplant (BMT) is a medical procedure used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. This treatment is commonly used for patients with blood disorders, cancers like leukemia, or other immune system deficiencies.
2. Who needs a bone marrow transplant?
Patients with conditions such as leukemia, lymphoma, aplastic anemia, sickle cell anemia, and certain immune disorders may require a BMT.
3. What are the types of bone marrow transplants?
The two main types are:
- Autologous transplant: Uses the patient’s own stem cells.
- Allogeneic transplant: Uses stem cells from a donor, who may be a relative or an unrelated matched donor.
4. How does the bone marrow transplant process work?
The process includes several steps:
- Preparation: Conditioning treatment with chemotherapy or radiation to destroy diseased cells.
- Stem cell infusion: Healthy stem cells are infused into the patient’s bloodstream.
- Engraftment: The new stem cells travel to the bone marrow and begin producing healthy blood cells.
5. What are the benefits of a bone marrow transplant?
A BMT can treat life-threatening diseases, restore the body’s ability to produce healthy blood cells, and improve or cure certain immune system disorders.
6. How long does the procedure take?
The actual stem cell infusion takes a few hours, but the entire process, including preparation and recovery, may take weeks or months.
7. Is bone marrow transplant painful?
The infusion itself is not painful, but the preparation phase involving chemotherapy or radiation can cause discomfort. Side effects are managed with medications.
8. What is the recovery time for a bone marrow transplant?
Recovery varies but typically requires several months to a year. Patients must follow strict infection-prevention measures during this time.
9. Are there risks associated with bone marrow transplants?
Yes, risks include infection, graft-versus-host disease (GVHD) (in allogeneic transplants), organ damage, and side effects from chemotherapy or radiation.
10. How is a donor match determined?
Matching is based on human leukocyte antigen (HLA) markers. Siblings or family members are often the best matches, but unrelated donors or cord blood may also be used.
11. Can bone marrow transplants cure cancer?
For certain cancers like leukemia and lymphoma, a bone marrow transplant can potentially lead to remission or cure.
12. What is engraftment, and how long does it take?
Engraftment occurs when the transplanted stem cells begin producing healthy blood cells. It typically takes 10 to 28 days post-transplant.
13. What are the eligibility criteria for a bone marrow transplant?
Eligibility depends on the patient’s overall health, the specific disease, and whether a suitable donor is available. A medical team evaluates each case individually.
14. Is hospitalization required for a bone marrow transplant?
Yes, patients usually stay in the JCI hospital for several weeks to monitor for complications and manage infections.
15. Can bone marrow transplants be performed in Istanbul or Antalya?
Yes, Istanbul and Antalya offer advanced bone marrow transplant facilities with experienced medical teams, making these cities popular destinations for this treatment.
16. How much does a bone marrow transplant cost in Istanbul and Antalya?
Costs vary widely but typically range from $20,000 to $70,000, depending on the type of transplant, donor availability, and additional care required.
17. What precautions are necessary after a bone marrow transplant?
Patients must take precautions to prevent infections, such as avoiding crowded places, following a strict hygiene routine, and adhering to their doctor’s instructions.
18. Can a bone marrow transplant fail?
Yes, transplant failure can occur if the stem cells do not engraft or if complications like severe infections or GVHD arise.
19. What is graft-versus-host disease (GVHD)?
GVHD is a condition where the donor’s immune cells attack the recipient’s tissues. It can range from mild to severe and is managed with medications.
20. Can children undergo bone marrow transplants?
Yes, children with certain cancers or genetic disorders are often candidates for BMT. Pediatric transplant specialists handle these cases.
21. How are stem cells collected for a bone marrow transplant?
Stem cells are collected from bone marrow, peripheral blood, or umbilical cord blood, depending on the procedure.
22. How do I prepare for a bone marrow transplant?
Preparation involves a thorough medical evaluation, discussion with a transplant team, and conditioning treatment with chemotherapy or radiation.
23. What is the role of a caregiver during recovery?
Caregivers provide essential support, including assistance with medications, monitoring for symptoms, and ensuring the patient follows their recovery plan.
24. Are bone marrow transplants covered by insurance?
Many insurance plans cover bone marrow transplants if they are medically necessary. Patients should confirm coverage with their provider.
25. Can I live a normal life after a bone marrow transplant?
Many patients regain normalcy after recovery, though ongoing medical check-ups and lifestyle adjustments are often necessary.
26. How do I find a donor for an allogeneic transplant?
Donors can be found through family members, donor registries like the Bone Marrow Donor Program, or public cord blood banks.
27. Are there alternatives to bone marrow transplants?
Alternatives may include immunotherapy, targeted therapy, or conventional chemotherapy, depending on the patient’s condition.
28. What are the survival rates for bone marrow transplants?
Survival rates depend on factors like the disease type, patient age, and transplant type. Generally, 60-90% of patients survive long-term with successful transplants.
29. Are there long-term side effects of a bone marrow transplant?
Potential long-term effects include infertility, organ damage, and risk of secondary cancers. Regular follow-ups help manage these risks.
30. What advancements are being made in bone marrow transplants?
Advancements include improved donor matching technologies, reduced-intensity conditioning regimens, and the use of gene therapy for certain genetic disorders.
.
| . FOR PATIENTS TO ARRIVE IN TURKEY, BEFORE WE ASK THEM TO SEND A MEDICAL REPORT OR TEST FOR OUR DOCTOR AT NO CHARGE TO PERFORM THE GENERAL EVALUATION BASED ON THESE. WE DO NOT INVITE PATIENTS WHOM WE BELIEVE THAT THE PROCEDURE WILL NOT YIELD GOOD RESULTS. SO MOST PATIENTS WHO ARRIVE IN TURKEY KNOWS CONDITIONS AND LIMITS OF THE TREATMENT, WHICH ENSURES OF EXPECTATIONS TO BE MET. . |
.
.
.
SUBMIT FORM
.
Please fill details below to evaluate the data and determine your Medical treatment eligibility. Turkey Medicals will contact you shortly with further instructions. For direct contact and questions you may reach the International Patient Helpline or WhatsApp.
.
.
.
.
.